Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of sample characteristics of Wisconsin Alzheimer's Disease Research Center participants with the Wisconsin state population-An evaluation of the recruitment effort.
Ma Y, Mora Pinzon MC, Buckingham WR, Bersch AJ, Powell WR, LeCaire TJ, Ennis GE, Deming Y, Jonaitis EM, Chin NA, Clark LR, Edwards DF, Walaszek A, Okonkwo OC, Zuelsdorff M, Chappell RJ, Johnson SC, Asthana S, Gleason CE, Kind AJ, Bendlin BB, Carlsson CM. Ma Y, et al. Among authors: gleason ce. Alzheimers Dement (N Y). 2025 Jan 16;11(1):e70036. doi: 10.1002/trc2.70036. eCollection 2025 Jan-Mar. Alzheimers Dement (N Y). 2025. PMID: 39822591 Free PMC article.
Menopausal hormone therapy is associated with worse levels of Alzheimer's disease biomarkers in APOE ε4-carrying women: An observational study.
Jauregi-Zinkunegi A, Gleason CE, Bendlin B, Okonkwo O, Hermann BP, Blennow K, Zetterberg H, Hogervorst E, Johnson SC, Langhough R, Mueller KD, Bruno D. Jauregi-Zinkunegi A, et al. Among authors: gleason ce. Alzheimers Dement. 2025 Jan 9. doi: 10.1002/alz.14456. Online ahead of print. Alzheimers Dement. 2025. PMID: 39783876
Perceptions about preclinical Alzheimer's disease biomarker collection procedure influences willingness to participate: Findings from an ethnoracially diverse study.
Gooding DC, Van Hulle CA, Zuelsdorff M, Lewis JP, Carter FP, Salazar H, Bouges S, James TT, Gee A, Gleason CE. Gooding DC, et al. Among authors: gleason ce. J Alzheimers Dis. 2025 Jan 8:13872877241307255. doi: 10.1177/13872877241307255. Online ahead of print. J Alzheimers Dis. 2025. PMID: 39772842
Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy.
Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Kendell-Thomas J, Kapoor E, Faubion LL, Schwarz CG, Senjem ML, Fields JA, Min PH, Lowe VJ, Jack CR Jr, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Kara F, et al. Among authors: gleason ce. Menopause. 2025 Jan 1;32(1):12-22. doi: 10.1097/GME.0000000000002481. Menopause. 2025. PMID: 39729067 Clinical Trial.
Implementation of a Social Media Strategy for Public Health Promotion in Black, American Indian or Alaska Native, and Hispanic or Latino Communities During the COVID-19 Pandemic: Cross-Sectional Study.
Mora Pinzon M, Hills O, Levy G, James TT, Benitez A, Lawrence S, Ellis T, Washington V, Solorzano L, Tellez-Giron P, Cano Ospina F, Metoxen MF, Gleason CE. Mora Pinzon M, et al. Among authors: gleason ce. J Med Internet Res. 2024 Dec 10;26:e58581. doi: 10.2196/58581. J Med Internet Res. 2024. PMID: 39657164 Free PMC article.
Long-term cognitive effects of menopausal hormone therapy: Findings from the KEEPS Continuation Study.
Gleason CE, Dowling NM, Kara F, James TT, Salazar H, Ferrer Simo CA, Harman SM, Manson JE, Hammers DB, Naftolin FN, Pal L, Miller VM, Cedars MI, Lobo RA, Malek-Ahmadi M, Kantarci K. Gleason CE, et al. PLoS Med. 2024 Nov 21;21(11):e1004435. doi: 10.1371/journal.pmed.1004435. eCollection 2024 Nov. PLoS Med. 2024. PMID: 39570992 Free PMC article. Clinical Trial.
Telomere length and cognitive function among middle-aged and older participants from communities underrepresented in aging research: A preliminary study.
McLester-Davis LWY, Norton D, Papale LA, James TT, Salazar H, Asthana S, Johnson SC, Gooding DC, Roy TR, Alisch RS, Hogan KJ, Drury SS, Gleason CE, Zuelsdorff M. McLester-Davis LWY, et al. Among authors: gleason ce. bioRxiv [Preprint]. 2024 Oct 16:2024.10.14.618331. doi: 10.1101/2024.10.14.618331. bioRxiv. 2024. PMID: 39464117 Free PMC article. Preprint.
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity.
Singh S, Gleason CE, Fang M, Laimon YN, Khivansara V, Xie S, Durmaz YT, Sarkar A, Ngo K, Savla V, Li Y, Abu-Remaileh M, Li X, Tuladhar B, Odeh R, Hamkins-Indik F, He D, Membreno MW, Nosrati M, Gushwa NN, Leung SSF, Fraga-Walton B, Hernandez L, Baldomero MP, Lent BM, Spellmeyer D, Luna JF, Hoang D, Gritsenko Y, Chand M, DeMart MK, Metobo S, Bhatt C, Shapiro JA, Yang K, Dupper NJ, Bockus AT, Doench JG, Aggen JB, Liu LF, Levin B, Wang EW, Vendrell I, Fischer R, Kessler B, Gokhale PC, Signoretti S, Spektor A, Kreatsoulas C, Singh R, Earp DJ, Garcia PD, Nijhawan D, Oser MG. Singh S, et al. Among authors: gleason ce. bioRxiv [Preprint]. 2024 Aug 1:2024.08.01.605889. doi: 10.1101/2024.08.01.605889. bioRxiv. 2024. PMID: 39211113 Free PMC article. Preprint.
136 results